Citation Tools

Download PDFPDF

Extended report
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

Download to a citation manager

Cite this article as:
Schiff M, Weinblatt ME, Valente R, et al
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial